Lasa Supergenerics adds oxyclozanide to its product portfolio
Setting up new capacity as a brownfield expansion, production to commence from August 2021
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
Lasa Supergenerics
LASA gets WHO GMP certificate for Khed Unit in Ratnagiri
WHO GMP covers all aspects of production starting from the materials, premises and equipment to the training and personal hygiene…
Lasa gets environmental clearance for benzimidazole derivatives capacity expansion at Khed facility
Lasa’s total volumetric capacity to increase by ~60 per cent to 6,800 TPA
ICT, Lasa succeed in Favipiravir drug synthesis, to commence production
The collaborators aim to manufacture close to 10,000 doses of the antiviral to begin with
Lasa Supergenerics gets FDA nod for progesterone API
Progesterone is one of the 26 drugs that had a restriction for exports due to COVID 19 pandemic as a result of India’s import…
Lasa and ICT explore Favipiravir therapy to fight COVID 19
Once the Favipiravir therapy is approved by global regulatory authorities we would approach DCGI for conducting required…
Lasa Supergenerics acquires Harishree Aromatics
In addition to the takeover of the manufacturing unit along with all other assets and liabilities whereas transferor is a…